Your browser doesn't support javascript.
loading
Effect of Once-Weekly Exenatide on Clinical Outcomes According to Baseline Risk in Patients With Type 2 Diabetes Mellitus: Insights From the EXSCEL Trial.
Mentz, Robert J; Bethel, M Angelyn; Merrill, Peter; Lokhnygina, Yuliya; Buse, John B; Chan, Juliana C; Felício, João S; Goodman, Shaun G; Choi, Jasmine; Gustavson, Stephanie M; Iqbal, Nayyar; Lopes, Renato D; Maggioni, Aldo P; Öhman, Peter; Pagidipati, Neha J; Poulter, Neil R; Ramachandran, Ambady; Reicher, Barry; Holman, Rury R; Hernandez, Adrian F.
Afiliação
  • Mentz RJ; 1 Duke Clinical Research Institute Duke University School of Medicine Durham NC.
  • Bethel MA; 2 Diabetes Trials Unit Oxford Centre for Diabetes, Endocrinology and Metabolism University of Oxford United Kingdom.
  • Merrill P; 1 Duke Clinical Research Institute Duke University School of Medicine Durham NC.
  • Lokhnygina Y; 1 Duke Clinical Research Institute Duke University School of Medicine Durham NC.
  • Buse JB; 3 Department of Medicine University of North Carolina School of Medicine Chapel Hill NC.
  • Chan JC; 4 Department of Medicine & Therapeutics The Chinese University of Hong Kong China.
  • Felício JS; 5 Hospital Universitário João de Barros Barreto-UFPA Belém Brazil.
  • Goodman SG; 6 St. Michael's Hospital University of Toronto Ontario Canada.
  • Choi J; 7 Canadian VIGOUR Centre University of Alberta Edmonton Alberta Canada.
  • Gustavson SM; 8 AstraZeneca Research and Development Gaithersburg MD.
  • Iqbal N; 8 AstraZeneca Research and Development Gaithersburg MD.
  • Lopes RD; 8 AstraZeneca Research and Development Gaithersburg MD.
  • Maggioni AP; 1 Duke Clinical Research Institute Duke University School of Medicine Durham NC.
  • Öhman P; 9 ANMCO Research Center Firenze Italy.
  • Pagidipati NJ; 8 AstraZeneca Research and Development Gaithersburg MD.
  • Poulter NR; 1 Duke Clinical Research Institute Duke University School of Medicine Durham NC.
  • Ramachandran A; 10 International Centre for Circulatory Health Imperial College London United Kingdom.
  • Reicher B; 11 India Diabetes Research Foundation and Dr. A. Ramachandran's Diabetes Hospitals Chennai India.
  • Holman RR; 8 AstraZeneca Research and Development Gaithersburg MD.
  • Hernandez AF; 2 Diabetes Trials Unit Oxford Centre for Diabetes, Endocrinology and Metabolism University of Oxford United Kingdom.
J Am Heart Assoc ; 7(19): e009304, 2018 10 02.
Article em En | MEDLINE | ID: mdl-30371301
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Medição de Risco / Diabetes Mellitus Tipo 2 / Exenatida Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Medição de Risco / Diabetes Mellitus Tipo 2 / Exenatida Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Ano de publicação: 2018 Tipo de documento: Article